Insider Trading History of Ho Carole


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ho Carole since year 2005. The trader's CIK number is 1724605. At the time of the last reporting, Ho Carole was the Chief Medical Officer of Denali Therapeutics Inc. . (stock ticker symbol DNLI). See this page for all insider trading activities at Denali Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Ho Carole since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-08-20 DNLI Denali Therapeutics Inc. Option Ex 5,643 .00 0
2019-07-08 DNLI Denali Therapeutics Inc. Option Ex 6,511 5.28 34,378
2019-07-08 DNLI Denali Therapeutics Inc. Sale 17,500 20.39 356,877
2019-06-10 DNLI Denali Therapeutics Inc. Option Ex 4,617 5.28 24,377
2019-06-10 DNLI Denali Therapeutics Inc. Sale 17,500 18.74 327,897
2019-05-10 DNLI Denali Therapeutics Inc. Sale 5,862 22.16 129,931
2019-05-09 DNLI Denali Therapeutics Inc. Sale 5,863 23.22 136,127
2019-05-08 DNLI Denali Therapeutics Inc. Sale 5,775 23.50 135,741
2019-05-10 DNLI Denali Therapeutics Inc. Option Ex 2,546 5.28 13,442
2019-05-09 DNLI Denali Therapeutics Inc. Option Ex 2,653 5.28 14,007
2019-05-08 DNLI Denali Therapeutics Inc. Option Ex 2,613 5.28 13,796
2019-04-04 DNLI Denali Therapeutics Inc. Sale 9,588 26.62 255,232
2019-04-03 DNLI Denali Therapeutics Inc. Sale 15,450 26.54 410,043
2019-04-02 DNLI Denali Therapeutics Inc. Sale 15,580 24.98 389,235
2019-04-03 DNLI Denali Therapeutics Inc. Option Ex 5,862 5.28 30,951
2019-04-01 DNLI Denali Therapeutics Inc. Sale 5,775 23.91 138,080
2019-04-02 DNLI Denali Therapeutics Inc. Option Ex 6,135 5.28 32,392
2019-04-01 DNLI Denali Therapeutics Inc. Option Ex 5,775 5.28 30,492
2019-03-14 DNLI Denali Therapeutics Inc. Option Ex 500 5.28 2,640
2019-03-14 DNLI Denali Therapeutics Inc. Sale 1,000 25.01 25,010
2019-03-01 DNLI Denali Therapeutics Inc. Option Ex 5,775 5.28 30,492
2019-03-01 DNLI Denali Therapeutics Inc. Sale 5,775 22.55 130,197
2019-03-04 DNLI Denali Therapeutics Inc. Option Ex 5,863 5.28 30,956
2019-03-05 DNLI Denali Therapeutics Inc. Option Ex 5,862 5.28 30,951
2019-03-04 DNLI Denali Therapeutics Inc. Sale 5,863 22.36 131,067
2019-03-05 DNLI Denali Therapeutics Inc. Sale 5,862 21.96 128,729
2019-02-04 DNLI Denali Therapeutics Inc. Option Ex 3,869 5.28 20,428
2019-02-01 DNLI Denali Therapeutics Inc. Sale 5,775 18.64 107,646
2019-02-01 DNLI Denali Therapeutics Inc. Option Ex 5,775 5.28 30,492
2019-02-05 DNLI Denali Therapeutics Inc. Sale 7,856 18.83 147,928
2019-02-04 DNLI Denali Therapeutics Inc. Sale 3,869 18.80 72,737
2019-02-05 DNLI Denali Therapeutics Inc. Option Ex 7,856 5.28 41,479
2019-01-04 DNLI Denali Therapeutics Inc. Sale 5,950 19.66 117,006
2019-01-03 DNLI Denali Therapeutics Inc. Sale 2,777 18.90 52,485
2019-01-04 DNLI Denali Therapeutics Inc. Option Ex 5,950 5.28 31,416
2019-01-02 DNLI Denali Therapeutics Inc. Sale 5,775 19.84 114,547
2019-01-03 DNLI Denali Therapeutics Inc. Option Ex 5,775 5.28 30,492
2018-12-03 DNLI Denali Therapeutics Inc. Sale 17,500 18.80 328,930
2018-11-15 DNLI Denali Therapeutics Inc. Sale 17,500 18.07 316,155
2018-10-01 DNLI Denali Therapeutics Inc. Sale 17,500 21.72 380,100
2018-09-04 DNLI Denali Therapeutics Inc. Sale 17,500 19.05 333,375
2018-08-29 DNLI Denali Therapeutics Inc. Sale 17,500 18.04 315,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Carole (Chief Medical Officer of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.